Antibody data
- Antibody Data
 - Antigen structure
 - References [3]
 - Comments [0]
 - Validations [0]
 
Submit
Validation data
Reference
Comment
Report error
- Product number
 - HPA010636 - Provider product page

 - Provider
 - Atlas Antibodies
 - Proper citation
 - Atlas Antibodies Cat#HPA010636, RRID:AB_1078447
 - Product name
 - Anti-CD164
 - Antibody type
 - Polyclonal
 - Description
 - Polyclonal Antibody against Human CD164, Gene description: CD164 molecule, sialomucin, Alternative Gene Names: MGC-24, MUC-24, Validated applications: WB, IHC, Uniprot ID: Q04900, Storage: Store at +4°C for short term storage. Long time storage is recommended at -20°C.
 - Reactivity
 - Human
 - Host
 - Rabbit
 - Conjugate
 - Unconjugated
 - Isotype
 - IgG
 - Vial size
 - 100 µl
 - Concentration
 - 0.1 mg/ml
 - Storage
 - Store at +4°C for short term storage. Long time storage is recommended at -20°C.
 - Handling
 - The antibody solution should be gently mixed before use.
 
Submitted references		RP11‑619L19.2 promotes colon cancer development by regulating the miR‑1271‑5p/CD164 axis
				
Identification of the Human Skeletal Stem Cell
				
Overexpression of CD164 in oral cavity squamous cell carcinoma predicts a favourable prognosis
				
		
	
			Zhang X, Li S, Zhang D, Sun X, Zhai H
Oncology Reports 2020;44(6):2419-2428
		Oncology Reports 2020;44(6):2419-2428
Identification of the Human Skeletal Stem Cell
			Chan C, Gulati G, Sinha R, Tompkins J, Lopez M, Carter A, Ransom R, Reinisch A, Wearda T, Murphy M, Brewer R, Koepke L, Marecic O, Manjunath A, Seo E, Leavitt T, Lu W, Nguyen A, Conley S, Salhotra A, Ambrosi T, Borrelli M, Siebel T, Chan K, Schallmoser K, Seita J, Sahoo D, Goodnough H, Bishop J, Gardner M, Majeti R, Wan D, Goodman S, Weissman I, Chang H, Longaker M
Cell 2018;175(1):43-56.e21
		Cell 2018;175(1):43-56.e21
Overexpression of CD164 in oral cavity squamous cell carcinoma predicts a favourable prognosis
			Chen J, Chen W, Chan J, Chen Y, Peng Y, Cheng M, Lin C
Oncology Letters 2017
		Oncology Letters 2017
				No comments: Submit comment	
	
			
			No validations: Submit validation data